Cheviot Value Management LLC Sells 125 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cheviot Value Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 956 shares of the healthcare conglomerate’s stock after selling 125 shares during the quarter. Cheviot Value Management LLC’s holdings in UnitedHealth Group were worth $487,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Resources Management Corp CT ADV boosted its stake in shares of UnitedHealth Group by 4.2% in the 2nd quarter. Resources Management Corp CT ADV now owns 13,839 shares of the healthcare conglomerate’s stock valued at $7,048,000 after purchasing an additional 563 shares during the last quarter. Lombard Odier Asset Management Europe Ltd lifted its position in shares of UnitedHealth Group by 72.7% during the 2nd quarter. Lombard Odier Asset Management Europe Ltd now owns 68,394 shares of the healthcare conglomerate’s stock valued at $34,830,000 after acquiring an additional 28,797 shares during the period. Evergreen Capital Management LLC lifted its position in shares of UnitedHealth Group by 7.7% during the 2nd quarter. Evergreen Capital Management LLC now owns 17,644 shares of the healthcare conglomerate’s stock valued at $8,985,000 after acquiring an additional 1,259 shares during the period. Magnetar Financial LLC lifted its position in shares of UnitedHealth Group by 100.7% during the 2nd quarter. Magnetar Financial LLC now owns 159,239 shares of the healthcare conglomerate’s stock valued at $81,094,000 after acquiring an additional 79,898 shares during the period. Finally, Public Sector Pension Investment Board lifted its position in shares of UnitedHealth Group by 26.3% during the 2nd quarter. Public Sector Pension Investment Board now owns 436,747 shares of the healthcare conglomerate’s stock valued at $222,418,000 after acquiring an additional 91,022 shares during the period. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Argus boosted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. HSBC upped their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Price Performance

UNH opened at $573.67 on Tuesday. The firm has a market cap of $528.00 billion, a P/E ratio of 35.07, a PEG ratio of 1.64 and a beta of 0.58. The firm has a 50-day moving average of $578.27 and a 200 day moving average of $521.81. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.14 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.